Valuation United Therapeutics Corporation

Equities

Market Closed - Nasdaq Other stock markets 00:00:00 06/06/2026 +04			5-day change	1st Jan Change
549.87 ^USD	+0.40%		-1.25%	+12.85%

06-04	United Therapeutics Insider Sold Shares Worth $5,114,742, According to a Recent SEC Filing	MT
06-03	United Therapeutics Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 12:45 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	9,731	12,674	10,333	15,752	20,979	23,340	-	-
Change	-	30.24%	-18.47%	52.44%	33.18%	11.25%	-	-
Enterprise Value (EV) ¹	9,637	12,513	8,039	12,785	18,059	19,973	18,755	16,450
Change	-	29.85%	-35.75%	59.04%	41.25%	10.6%	-6.1%	-12.29%
P/E ratio	21.5x	18.5x	11.1x	14.3x	17.5x	20.1x	17.4x	14.9x
PBR	2.67x	2.67x	1.73x	2.47x	3x	2.83x	2.41x	1.85x
PEG	-	0.4x	0.3x	0.6x	1.3x	-10.23x	1.1x	0.9x
Capitalization / Revenue	5.77x	6.55x	4.44x	5.47x	6.59x	7.15x	6.31x	5.46x
EV / Revenue	5.72x	6.46x	3.45x	4.44x	5.67x	6.12x	5.07x	3.85x
EV / EBITDA	15.9x	12.1x	6.49x	8.82x	11.4x	12x	9.75x	7.71x
EV / EBIT	17.3x	12.8x	6.78x	9.28x	12.1x	13x	10.5x	7.84x
EV / FCF	20.2x	18.9x	10.8x	11.8x	17.4x	15.9x	12.7x	8.61x
FCF Yield	4.95%	5.3%	9.3%	8.45%	5.76%	6.27%	7.9%	11.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	10.06	15	19.81	24.64	27.86	27.31	31.62	36.93
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,686	1,936	2,328	2,877	3,183	3,264	3,700	4,274
EBITDA ¹	605.8	1,031	1,238	1,450	1,578	1,663	1,924	2,134
EBIT ¹	555.9	979.7	1,185	1,377	1,492	1,533	1,789	2,099
Net income ¹	475.8	727.3	984.8	1,195	1,335	1,273	1,481	1,747
Net Debt ¹	-94.8	-161.2	-2,294	-2,967	-2,920	-3,367	-4,585	-6,890
Reference price ²	216.08	278.09	219.89	352.84	487.25	549.87	549.87	549.87
Nbr of stocks (in thousands)	45,037	45,577	46,994	44,645	43,057	42,447	-	-
Announcement Date	24/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UNITED THERAPEUTICS CORPORATION	20.13x	6.12x	12.01x	-.--%	23.34B
ELI LILLY AND COMPANY	33.11x	12.04x	24.78x	0.6%	1,009B
JOHNSON & JOHNSON	24.88x	5.74x	15.6x	2.29%	560B
ABBVIE INC.	27.82x	6.77x	13.84x	3.02%	401B
ROCHE HOLDING AG	17.55x	4.34x	10.65x	3.07%	328B
ASTRAZENECA PLC	23.42x	4.85x	13.81x	1.8%	288B
NOVARTIS AG	20.62x	5.32x	12.95x	3.06%	272B
NOVO NORDISK A/S	12.56x	4.71x	9.62x	4%	194B
AMGEN INC.	22.73x	6.08x	10.62x	2.89%	189B
GILEAD SCIENCES, INC.	-46.22x	5.58x	31.48x	2.51%	160B
Average	15.66x	6.15x	15.54x	2.32%	342.5B
Weighted average by Cap.	22.31x	7.43x	17.37x	2.1%